Puma Biotechnology Inc (PBYI): Are Hedge Funds Right About This Stock? – Exelixis, Inc. (EXEL), NPS Pharmaceuticals, Inc. (NPSP)

Page 1 of 2

Is Puma Biotechnology Inc (NYSE:PBYI) going to take off soon? Prominent investors are becoming hopeful. The number of long hedge fund bets improved by 9 in recent months.

Puma Biotechnology Inc

In the eyes of most market participants, hedge funds are viewed as unimportant, old financial vehicles of years past. While there are over 8000 funds trading at the moment, we look at the upper echelon of this group, around 450 funds. It is widely believed that this group has its hands on the majority of the hedge fund industry’s total capital, and by watching their best equity investments, we have spotted a number of investment strategies that have historically beaten the S&P 500 index. Our small-cap hedge fund strategy beat the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have outpaced the S&P 500 index by 24 percentage points in 7 months (check out a sample of our picks).

Equally as beneficial, optimistic insider trading activity is a second way to break down the stock market universe. As the old adage goes: there are lots of incentives for a corporate insider to get rid of shares of his or her company, but only one, very clear reason why they would behave bullishly. Many academic studies have demonstrated the valuable potential of this method if shareholders understand where to look (learn more here).

Consequently, it’s important to take a peek at the latest action encompassing Puma Biotechnology Inc (NYSE:PBYI).

How are hedge funds trading Puma Biotechnology Inc (NYSE:PBYI)?

At the end of the fourth quarter, a total of 11 of the hedge funds we track held long positions in this stock, a change of 450% from one quarter earlier. With hedgies’ sentiment swirling, there exists an “upper tier” of notable hedge fund managers who were increasing their holdings substantially.

Of the funds we track, Adage Capital Management, managed by Phill Gross and Robert Atchinson, holds the largest position in Puma Biotechnology Inc (NYSE:PBYI). Adage Capital Management has a $98.3 million position in the stock, comprising 0.4% of its 13F portfolio. Sitting at the No. 2 spot is Samuel Isaly of OrbiMed Advisors, with a $15.9 million position; the fund has 0.5% of its 13F portfolio invested in the stock. Other peers that are bullish include Bain Capital’s Brookside Capital, Steven Cohen’s SAC Capital Advisors and Dmitry Balyasny’s Balyasny Asset Management.

Now, key hedge funds have jumped into Puma Biotechnology Inc (NYSE:PBYI) headfirst. OrbiMed Advisors, managed by Samuel Isaly, assembled the most valuable position in Puma Biotechnology Inc (NYSE:PBYI). OrbiMed Advisors had 15.9 million invested in the company at the end of the quarter. Steven Cohen’s SAC Capital Advisors also initiated a $9.4 million position during the quarter. The other funds with brand new PBYI positions are Dmitry Balyasny’s Balyasny Asset Management, Sean Cullinan’s Point State Capital, and Jacob Gottlieb’s Visium Asset Management.

How have insiders been trading Puma Biotechnology Inc (NYSE:PBYI)?

Insider buying is particularly usable when the primary stock in question has seen transactions within the past six months. Over the last half-year time frame, Puma Biotechnology Inc (NYSE:PBYI) has experienced 2 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to Puma Biotechnology Inc (NYSE:PBYI). These stocks are Exelixis, Inc. (NASDAQ:EXEL), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), PDL BioPharma Inc. (NASDAQ:PDLI), Celldex Therapeutics, Inc. (NASDAQ:CLDX), and MannKind Corporation (NASDAQ:MNKD). All of these stocks are in the biotechnology industry and their market caps resemble PBYI’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Top 10 Most Expensive Luxury Cars in the World – 2014

Killer Small Business Ideas

The 50 Best Personal Finance Blogs

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!